Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
IRESSA (Gefitinib) Receives Marketing Authorisation for the Treatment of Non-Small Cell Lung Cancer in Europe
-
AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
-
ONGLYZA (saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes
-
Favourable Vote from FDA Advisory Committee on Seroquel Paediatric Supplemental New Drug Applications
-
AstraZeneca and Abbott Extend Relationship to Include Co-Promotion of Trilipix
-
AstraZeneca and Abbott Submit New Drug Application to the FDA for the Approval of CERTRIAD for the Treatment of Mixed Dyslipidemia
-
AstraZeneca and Merck & Co., Inc. Form Pioneering Collaboration to Investigate Novel Combination Anticancer Regimen
-
AstraZeneca Regulatory Update on Seroquel XR for the Treatment of Major Depressive Disorder
-
Court Grants AstraZeneca Preliminary Injunction Against Apotex in Pulmicort Respules Patent Litigation
-
AstraZeneca Announces Top Line Results From Pivotal Phase III Study for BRILINTA
Latest articles and press releases
All of our latest press releases and articles are available to explore
